Delivery Order 75N98019D00058-75N98020F00002
- The National Institutes of Health, Office of Logistics and Acquisition Operations awarded a $10,198 firm fixed price delivery order to Societal Cdmo San Diego, LLC under the Drug Formulation and Manufacturing Contracts 2019 indefinite-delivery/indefinite-quantity multiple award contract vehicle. Societal Cdmo San Diego, LLC will perform stability drug testing of decitabine capsules according to Document Number X-QC-013-02 in the statement of work. Irisys, Inc. is the parent company of prime...
- This is a $17,542 Cost Plus Fixed Fee delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business. The contract is for the production and evaluation of the stability of tetrathiomolibdate capsules in a non-GMP study. This award is part of Societal CDMO San Diego's work...
- This is a delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Societal Cdmo San Diego, LLC, a small disadvantaged business contract development and manufacturing organization (CDMO). The $505,500.00 contract is for the development and manufacture of a novobiocin capsule product, including a 36-month shelf-life study, in support of NIH's cancer research programs. The award is issued under the Drug Formulation...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded a $750,000 firm fixed price delivery order contract to Medical Science & Computing, LLC. The contract is to conduct a public health and economic impact study of the National Institutes of Health's intramural technology transfer licensing activities. Performance will take place in Rockville, Maryland over an 18-month period concluding in March 2023. No set aside designation or...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $1,596,279.92 cost-plus-fixed-fee delivery order contract to Midwest Research Institute (doing business as Mriglobal), a not-for-profit research organization, under the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery/indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation. Key subcontractors include the University...
- Medical Science & Computing, LLC has been awarded a $3.1 million firm fixed price delivery order by the Department of Health and Human Services' National Institutes of Health Office of Logistics and Acquisition Operations to provide CGMP manufacture of GS-441524 for the National Center for Advancing Translational Sciences' Division of Preclinical Innovation and Testing's Therapeutics for Rare and Neglected Diseases program. The contract runs from April 2021 through December 2023 for the...
- This federal contract award was issued by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a small disadvantaged business. The $30,496.00 task order is for a study to examine the stabilizing effect of the Stabilox system on tetra thiomolybdate. This work is being performed under the NCI's $45 million Drug Formulation and Manufacturing Contracts 2019 multiple-award Indefinite...
- This is a delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to MRIGlobal, a not-for-profit research organization also known as Midwest Research Institute. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ contract vehicle and has a potential value of $1,535,538.00. The contract does not have a set-aside designation. Under this contract,...
- This is a $760,749 firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The order is to provide dosage form development, manufacturing, and stability studies of the investigational drug ORC-13661 for a Phase II clinical trial. This delivery order was issued under the NCATS Drug Product Development Studies 2017-2022 indefinite...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,069,827.48 delivery order against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery, indefinite-quantity master contract to Medical Science & Computing, LLC. The firm fixed price order is for Scientific, Operations, and Administrative Resources to the NIH and will be performed in Rockville, Maryland over a...
- 75N98019D00058Indefinite Delivery Contract
- 75N98019D00058-75N98020F00002Delivery Order
The National Institutes of Health (NIH), an agency of the Department of Health and Human Services, awarded an $11,000 firm fixed price delivery order to Societal Cdmo San Diego, LLC for stability studies required by Good Manufacturing Practices for a finished pharmaceutical product containing mithramycin lyophilized powder for injection. The delivery order was issued against the prime contractor's master indefinite-delivery/indefinite-quantity contract vehicle known as the Drug Formulation and Manufacturing Contracts 2019, which was awarded by NIH in 2019 to provide various drug formulation and manufacturing services. Performance will occur in Rockville, Maryland through September 2021. No set aside designations or major subcontractors were indicated. The award will support NIH's medical research mission by facilitating development and testing of an investigational drug candidate.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 9/18/20 |